|
| Prognostic predictors | Sensitivity
% (95% CI)
1–3 d/4–7 d | Specificity
% (95% CI)
1–3 d/4–7 d | Positive predictive value % (95% CI)
1–3 d/4–7 d | Negative predictive value
% (95% CI)
1–3 d /4–7 d | Positive likelihood ratios
% (95% CI)
1–3 d/4–7 d |
|
| GCS | | | | | |
| 3–5 | 22.5 (14.6–32.8)/
62.9 (52.0–72.7) | 85.1 (73.8–92.2)/
80.6 (68.8–88.9) | 66.7 (47.1–82.1)/
81.2 (69.6–89.2) | 45.2 (36.4–54.3)/
62.1 (51.0–72.1) | 1.51 (0.76–3.00)/
3.24 (1.94–5.42) |
| SLSEP | | | | | |
| Abnormality of N20 | 96.6 (89.8–99.1)/
100 (94.8–100) | 17.9 (90.0–29.6)/
26.9 (17.1–39.3) | 61.0 (52.4–69.0)/
64.5 (55.8–72.3) | 80.0 (51.4–94.7)/
100 (78.1–100) | 1.18 (1.05–1.33)/
1.37 (1.18–1.58) |
| Bilateral absence of N20 | 6.7 (2.8–14.6)/
48.3 (37.7–59.1) | 100 (93.2–100)/
100 (93.2–100) | 100 (51.7–100)/
100 (89.8–100) | 44.7 (36.6–53.0)/
59.3 (49.6–68.3) | 9.10 (0.52–160.13)/
65.22 (4.09–1040.76) |
| BAEP | | | | | |
| Abnormality of V | 75.3 (64.8–83.5)/
91.0 (82.6–95.8) | 37.3 (26.1–50.0)/
43.3 (31.4–55.9) | 61.5 (51.6–70.5)/
68.1 (58.8–76.1) | 53.2 (38.2–67.6)/
78.4 (61.3–89.3) | 1.20 (0.96–1.50)/
1.60 (1.29–2.00) |
| Bilateral absence of V | 11.2 (5.8–20.1)/
38.2 (28.3–49.2) | 100 (93.2–100)/
100 (93.2–100) | 100 (65.5–100)/
100 (87.4–100) | 45.9 (37.7–54.3)/
54.9 (45.7–63.9) | 15.17 (0.91–255.14)/
51.57 (3.22–826.44) |
|
